G-CSF can be administered for 2 to 3 consecutive days between Day 4 and Day 6 if neutropenia occurs on Day 1 of the treatment cycle, or as a single dose in pegylated form on Day 9 or Day 10 if neutropenia occurs on Day 8 [33]. This evidence concerns the gene CSF3 and Decreased total neutrophil count.